These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 2682551)

  • 1. Treatment of hypertension in the elderly with labetalol.
    Sirgo MA; Boyd BK; Applegate WB
    Pharmacotherapy; 1989; 9(5):295-302. PubMed ID: 2682551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous labetalol in the emergency treatment of hypertension.
    Vidt DG
    J Clin Hypertens; 1985 Jun; 1(2):179-86. PubMed ID: 3915322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of hypertension with labetalol in neurosurgical practice. Influence of labetalol on cerebral perfusion pressure in dogs without and with intracranial mass lesions.
    Puchstein C; van Aken H; Hidding J; Anger C; Lawin P
    Acta Neurochir (Wien); 1983; 67(3-4):283-90. PubMed ID: 6846084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemodynamic effects of labetalol in young and older adult hypertensives.
    Buell JC; Eliot RS; Plachetka JR; Little MR
    J Clin Pharmacol; 1988 Apr; 28(4):327-31. PubMed ID: 3392230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of hypertension in the elderly with labetalol.
    Eisalo A; Virta P
    Acta Med Scand Suppl; 1982; 665():129-33. PubMed ID: 6961759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haemodynamic effects of long-term oral labetalol.
    Edwards RC; Raftery EB
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):733-6. PubMed ID: 791328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemodynamic effects of labetalol, an alpha and beta adrenergic blocking agent, in hypertensive subjects.
    Mehta J; Cohn JN
    Circulation; 1977 Feb; 55(2):370-5. PubMed ID: 12880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacology of combined alpha-beta-blockade. II. Haemodynamic effects of labetalol.
    Lund-Johansen P
    Drugs; 1984; 28 Suppl 2():35-50. PubMed ID: 6151890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic, pulmonary, and coronary hemodynamic effects of labetalol in hypertensive subjects.
    Mehta J; Feldman RL; Marx JD; Kelly GA
    Am J Med; 1983 Oct; 75(4A):32-9. PubMed ID: 6638039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Changes in rest and exercise hemodynamics during long term therapy with a combination alpha and beta blocker in essential hypertension].
    Koch G
    Verh Dtsch Ges Kreislaufforsch; 1977; 43():219-20. PubMed ID: 349925
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacologic and physiologic considerations of adrenoceptor blockade.
    Frohlich ED; Dunn FG; Messerli FH
    Am J Med; 1983 Oct; 75(4A):9-14. PubMed ID: 6139019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of single-dose atenolol, labetalol, and propranolol on cardiac and vascular function.
    Holtzman JL; Finley D; Johnson B; Berry DA; Sirgo MA
    Clin Pharmacol Ther; 1986 Sep; 40(3):268-73. PubMed ID: 3742933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A study of labetalol, a new alpha- and beta-adrenoceptor blocking agent, in humans.
    Vas A; Gachályi B; Káldor A
    Int J Clin Pharmacol Ther Toxicol; 1982 Oct; 20(10):491-2. PubMed ID: 7141757
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of effects on cerebral blood flow of rapid reduction in systemic arterial pressure by diazoxide and labetalol in hypertensive patients: preliminary findings.
    Pearson RM; Griffith DN; Woollard M; James IM; Havard CW
    Br J Clin Pharmacol; 1979; 8(Suppl 2):195S-198S. PubMed ID: 526401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An in-depth analysis of vasodilation in the management of hypertension: focus on adrenergic blockade.
    Bakris G
    J Cardiovasc Pharmacol; 2009 May; 53(5):379-87. PubMed ID: 19454898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haemodynamic effects of atenolol, labetalol, pindolol and captopril: a comparison in hypertensive patients with special reference to changes in limb blood flow, heart rate and left ventricular function.
    Roberts DH; Tsao Y; Grimmer SF; Winstanley PA; Orme ML; Breckenridge AM
    Br J Clin Pharmacol; 1987 Aug; 24(2):163-72. PubMed ID: 2887190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of labetalol in the treatment of severe drug-resistant hypertension.
    Morgan T; Gillies A; Morgan G; Adam W
    Med J Aust; 1978 Apr; 1(7):393-6. PubMed ID: 672730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison in young and elderly patients of pharmacodynamics and disposition of labetalol in systemic hypertension.
    Abernethy DR; Schwartz JB; Plachetka JR; Todd EL; Egan JM
    Am J Cardiol; 1987 Sep; 60(8):697-702. PubMed ID: 3661438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haemodynamic effects of combined alpha- and beta-adrenoreceptor blockade after intravenous labetalol in hypertensive patients at rest and during exercise.
    Koch G
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):725-8. PubMed ID: 10950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The treatment of hypertension by labetalol--a new alpha- and beta-adrenoreceptor blocking agent.
    Stern N; Teicher A; Rosenthal T
    Clin Cardiol; 1982 Feb; 5(2):125-30. PubMed ID: 7039899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.